Uganda, WHO and Africa CDC deepen collaboration to strengthen regional health security - WHO | Regional Office for Africa

From eating habits to sleep and exercise, a national survey examines how teenagers' cardiovascular health differs across student groups and where schools could make a difference. Report: Cardiovascular Health Among High School Students - Youth Risk Behavior Survey, United States, 2025. Image Credit: EugeneEdge / Shutterstock

The CDC briefly pub­lished a web­page that main­tained un­equiv­o­cal sup­port for Covid-19 vac­cines in peo­ple prepar­ing to have a ba­by, but it now redi­rects else­where … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

[Editor's note: The authors of the report were misidentified in the original version of this story. The story has since been corrected. CIDRAP News regrets the error.]Measles is sometimes dismissed as an unserious disease or ‘just a rash.’ But the highly contagious virus can cause serious illness not just during initial infection but years later, after patients appear to have made a full recovery. This delayed complication, a rare, almost invariably fatal brain disease known as subacute sclerosing panencephalitis (SSPE), is highlighted in a new report published yesterday in Emerging Infectious Diseases. For the report, researchers in the Philippines looked at 20 children from that country, where measles outbreaks occurred in 2010–11, 2013, and 2018-19. The most recent outbreak was the largest in the World Health Organization Western Pacific Region. All children in the report were admitted to the pediatric hospital in Quezon City from 2007 through 2022. Larger wave of SSPE may be on horizonAll four children with estimated measles infection dates corresponding to the 2018-19 outbreak were hospitalized between 2020 and 2022, two to three years after their initial infections.

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.